-
1681por Hearle, N, Humphreys, J, Damato, B E, Wort, R, Talaban, R, Wixey, J, Green, H, Easton, D F, Houlston, R S“…Variants of the melanocortin-1 receptor (MC1R) gene have been linked to sun-sensitive skin types and hair colour, and may independently play a role in susceptibility to cutaneous melanoma. To assess the role of MC1R variants in uveal melanoma, we have analysed a cohort of 350 patients for the changes within the major region of the gene displaying sequence variation. …”
Publicado 2003
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1682por Viros, Amaya, Fridlyand, Jane, Bauer, Juergen, Lasithiotakis, Konstantin, Garbe, Claus, Pinkel, Daniel, Bastian, Boris C“…BACKGROUND: In melanoma, morphology-based classification systems have not been able to provide relevant information for selecting treatments for patients whose tumors have metastasized. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1683por Shields, J D, Borsetti, M, Rigby, H, Harper, S J, Mortimer, P S, Levick, J R, Orlando, A, Bates, D O“…Malignant melanoma (MM), the most common cause of skin cancer deaths, metastasises to regional lymph nodes. …”
Publicado 2004
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1684“…BACKGROUND: Primary cutaneous melanoma of the breast is a very rare tumour, accounting for < 5% of all malignant melanomas. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1685
-
1686
-
1687
-
1688
-
1689por Quintana, Elsa, Shackleton, Mark, Sabel, Michael S., Fullen, Douglas R., Johnson, Timothy M., Morrison, Sean J.“…Studies on diverse cancers, including melanoma, have indicated that only rare human cancer cells (0.1% to 0.0001%) have tumorigenic potential when transplanted into NOD/SCID mice. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1690“…Future efforts may well build toward patient-oriented therapy based upon the knowledge of the unique molecular features of this disease and the immune system of each melanoma patient.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1691por Manidakis, Nikolaos, Polyzois, Ioannis, Tsialogiannis, Euaggelos, Marples, Maria, Boon, Andrew, Tsiridis, Eleftherios“…BACKGROUND: Malignant melanoma of the conjunctiva is an extremely rare non-cutaneous neoplasm with infrequent skeletal metastatic spread. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1692“…Melanoma growth, angiogenesis and metastatic progression are strongly promoted by the inflammatory tumor microenvironment due to high levels of cytokine and chemokine secretion by the recruited inflammatory and stromal cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1693“…Qualitative and quantitative changes in matricellular protein expression contribute to melanoma progression similar to the E-cadherin to N-cadherin class switch, allowing melanoma cells to escape from keratinocyte control.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1694“…The discovery of BRAF mutations in melanoma has not yet translated into clinical success, suggesting that BRAF/MEK inhibitors will need to be combined with other agents. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1695“…Proteome serology may complement expression library-based approaches as strategy utilizing the patients' immune responses for the identification pathogenesis factors and potential targets for therapy and markers for diagnosis. Melanoma is a relatively immunogenic tumor and antigens recognized by melanoma-specific T cells have been extensively studied. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1696“…Malignant melanoma is the most common primary malignant tumour arising on the foot. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1697“…The primary malignant melanoma of the esophagus (PMME) is a rare malignant disease, accounting for only 0.1–0.2% of all esophageal neoplasms, and the majority of the patients are diagnosed at advanced stages with poor prognosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1698“…Malignant melanoma is a life-threatening skin cancer due to its highly metastatic character and resistance to radio- and chemotherapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1699“…Immunologic treatment strategies are established in malignant melanoma treatment, mainly focusing on Interleukin-2 in advanced disease and interferon alpha in the adjuvant situation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1700por Tan, Annelie N, Hoevenaars, Juliette GMM, Webers, Carroll AB, Damato, Bertil, Beckers, Henny JM“…BACKGROUND: Proton beam therapy (PBT) is effective in the treatment of iris melanoma. Reported complications after PBT are radiation-induced cataract and raised intraocular pressure (IOP). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Texto